Skip to main content
. 2019 Nov 27;4(6):e00532-19. doi: 10.1128/mSphere.00532-19

FIG 3.

FIG 3

Differences in the presence/absence and relative abundance of the most prevalent taxa in CRS patients versus healthy controls (CON). (A) Correlation between the presence of ASVs in healthy controls and CRS patients in the anterior nares (left) and the nasopharynx (right). A Fisher exact test was used to test for the significance of ASVs that were more present in healthy controls or CRS patients (P ≤ 0.05). Only ASVs with a significant presence and more than 25% presence under at least one of the conditions are shown with a name label. (B) Correlation between the mean relative abundance of ASVs in the anterior nares (left) and the nasopharynx (right) of healthy controls and CRS patients. Only ASVs with a mean relative abundance of greater than 30% under at least one of the conditions are shown with a name label.